Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Connect Biopharma Holdings (CNTB) EBITDA (2024 - 2025)

Historic EBITDA for Connect Biopharma Holdings (CNTB) over the last 2 years, with Q3 2025 value amounting to -$17.1 million.

  • Connect Biopharma Holdings' EBITDA fell 3897.29% to -$17.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$50.0 million, marking a year-over-year change of. This contributed to the annual value of -$16.3 million for FY2024, which is 7388.64% up from last year.
  • As of Q3 2025, Connect Biopharma Holdings' EBITDA stood at -$17.1 million, which was down 3897.29% from -$12.7 million recorded in Q2 2025.
  • In the past 5 years, Connect Biopharma Holdings' EBITDA ranged from a high of $14.9 million in Q2 2024 and a low of -$17.1 million during Q3 2025